(in millions $) | 30 Oct 2024 | 2 Mar 2024 | 3 Dec 2023 | 4 Sep 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $921 | $1210 | ||
Short term investments | $307 | $321 | ||
Net receivables | ||||
Inventory | $16894 | $17530 | $17422 | |
Total current assets | $19071 | $19968 | $22236 | |
Long term investments | $252 | $238 | ||
Property, plant & equipment | $21386 | $21174 | $21023 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $22724 | $22551 | ||
Total investments | $559 | $559 | ||
Total assets | $41795 | $42519 | $44521 | |
Current liabilities | ||||
Accounts payable | $8704 | $9914 | $10333 | |
Deferred revenue | $2633 | $2727 | ||
Short long term debt | $1024 | $1077 | ||
Total current liabilities | $15568 | $16496 | $17612 | |
Long term debt | $35384 | $35374 | $35839 | |
Total noncurrent liabilities | $41277 | $41170 | ||
Total debt | $40145 | $40053 | ||
Total liabilities | $56845 | $57666 | $59253 | |
Shareholders' equity | ||||
Retained earnings | -$15637 | -$15744 | -$15341 | |
Other shareholder equity | $300 | $302 | $306 | |
Total shareholder equity | -$15050 | -$15147 |
(in millions $) | 2 Mar 2024 | 3 Mar 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $921 | $1348 | $4690 | $4690 |
Short term investments | $307 | $384 | $271 | $506 |
Net receivables | ||||
Inventory | $16894 | $18532 | $16193 | $16193 |
Total current assets | $19071 | $21442 | $22326 | $22326 |
Long term investments | $252 | $121 | $199 | $200 |
Property, plant & equipment | $21386 | $21085 | $19155 | $22987 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $22724 | $22266 | $24409 | $24409 |
Total investments | $559 | $505 | $470 | $706 |
Total assets | $41795 | $43708 | $46735 | $46735 |
Current liabilities | ||||
Accounts payable | $8704 | $10524 | $10884 | $10884 |
Deferred revenue | $2633 | $2804 | $1608 | $2627 |
Short long term debt | $1024 | $1606 | $1504 | $1653 |
Total current liabilities | $15568 | $19511 | $18730 | $18730 |
Long term debt | $35384 | $32876 | $20668 | $24558 |
Total noncurrent liabilities | $41277 | $38451 | $26568 | $26568 |
Total debt | $40145 | $37994 | $29384 | $26211 |
Total liabilities | $56845 | $57962 | $45298 | $45298 |
Shareholders' equity | ||||
Retained earnings | -$15637 | -$14862 | $1117 | $1117 |
Other shareholder equity | $300 | $307 | -$136 | -$136 |
Total shareholder equity | -$15050 | -$14254 | -$4816 | $1437 |
(in millions $) | 30 Oct 2024 | 2 Mar 2024 | 3 Dec 2023 | 4 Sep 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $18602 | $20471 | $24956 | |
Cost of revenue | ||||
Gross Profit | $6026 | $6891 | $8399 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $4339 | $4195 | $4513 | |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $319 | $578 | $872 | |
Interest expense | -$348 | -$343 | -$341 | |
Net income | ||||
Net income | $1017 | $1769 | $2666 | |
Income (for common shares) |
(in millions $) | 2 Mar 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $86377 | $96250 | $89597 | |
Cost of revenue | $64194 | $60025 | ||
Gross Profit | $28844 | $32056 | $29572 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $18301 | $18526 | ||
Total operating expenses | $17287 | $19963 | $19925 | |
Operating income | $12093 | $9647 | ||
Income from continuing operations | ||||
EBIT | $12093 | $8587 | ||
Income tax expense | $2449 | $2766 | $1904 | |
Interest expense | -$1382 | $885 | $848 | |
Net income | ||||
Net income | $7706 | $8442 | $5835 | |
Income (for common shares) | $8442 | $5835 |
(in millions $) | 2 Mar 2024 | 3 Dec 2023 | 4 Sep 2023 | 5 Jun 2023 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$1901 | -$1306 | -$715 | -$304 |
Financing activities | ||||
Dividends paid | -$2531 | -$1899 | -$1257 | -$633 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$6666 | -$5864 | -$3107 | -$200 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$427 | -$138 | $2146 | $1602 |
(in millions $) | 2 Mar 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $6437 | $8442 | $5835 | |
Operating activities | ||||
Depreciation | $2511 | $2399 | $2073 | |
Business acquisitions & disposals | $491 | |||
Stock-based compensation | $223 | $230 | $155 | |
Total cash flows from operations | $8589 | $10113 | $11049 | |
Investing activities | ||||
Capital expenditures | -$1784 | -$1740 | -$1701 | |
Investments | -$15 | $228 | -$168 | |
Total cash flows from investing | -$1901 | -$1309 | -$1646 | -$1894 |
Financing activities | ||||
Dividends paid | -$2531 | -$2370 | -$1984 | -$1704 |
Sale and purchase of stock | -$13973 | -$12880 | -$4819 | |
Net borrowings | $9299 | $2854 | $1370 | |
Total cash flows from financing | -$6666 | -$7049 | -$12016 | -$5191 |
Effect of exchange rate | -$16 | -$8 | $10 | |
Change in cash and equivalents | -$427 | $215 | -$3557 | $3974 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | -3.78 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |